(Circulation. 1999;100:2140.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Mayo Clinic (R.J.G., D.O.H., K.R.B), Rochester, Minn; Cedars Sinai Medical Center (D.S.B., R.H.), Los Angeles, Calif; Allegheny University of the Health Sciences (J.H., A.E.I.), Philadelphia, Pa; and Columbia University (O.O.A.), New York, NY.
Correspondence to Raymond J. Gibbons, MD, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, East 16 A, Rochester, MN 55905. E-mail gibbons.raymond{at}mayo.edu
BackgroundThe appropriate management of patients with intermediate-risk Duke treadmill scores is not established. The purpose of this study was to determine the long-term risk of subsequent cardiovascular events in patients with an intermediate-risk treadmill score who do not have myocardial perfusion defects on radionuclide imaging.
Methods and ResultsThe existing databases of the nuclear cardiology laboratories of 4 academic institutions were searched retrospectively. A total of 4649 patients were identified who had intermediate-risk Duke treadmill scores (-10 to 4), normal or near-normal exercise single photon-emission computed tomographic myocardial perfusion images using either thallium-201 or technetium-99m sestamibi, and no previous coronary revascularization. Follow-up was 95% complete. Cardiovascular survival was 99.8% at 1 year, 99.0% at 5 years, and 98.5% at 7 years. Cardiac survival free of myocardial infarction was similarly high at 96.6% at 7 years. Cardiac survival free of myocardial infarction or revascularization was 87.1% at 7 years. Near-normal scans and cardiac enlargement were independent predictors of time to cardiac death. Seven-year cardiac survival was still high at 97.0% in the 357 patients with near-normal scans and normal cardiac size and somewhat lower, at 89.0%, in the 167 patients with cardiac enlargement.
ConclusionsPatients with an intermediate-risk treadmill score but with normal or near-normal exercise myocardial perfusion images and normal cardiac sizes are at low risk for subsequent cardiac death and can be safely managed medically until their symptoms warrant revascularization. The appropriate management of patients with cardiac enlargement will remain a matter of clinical judgment.
Key Words: exercise radioisotopes coronary disease
This article has been cited by other articles:
![]() |
G. D. Harris and R. D. White Exercise Stress Testing in Patients With Type 2 Diabetes: When Are Asymptomatic Patients Screened? Clin. Diabetes, October 1, 2007; 25(4): 126 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Berman, R. Hachamovitch, L. J. Shaw, J. D. Friedman, S. W. Hayes, L. E.J. Thomson, D. S. Fieno, G. Germano, N. D. Wong, X. Kang, et al. Roles of Nuclear Cardiology, Cardiac Computed Tomography, and Cardiac Magnetic Resonance: Noninvasive Risk Stratification and a Conceptual Framework for the Selection of Noninvasive Imaging Tests in Patients with Known or Suspected Coronary Artery Disease J. Nucl. Med., July 1, 2006; 47(7): 1107 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elhendy, A. F.L. Schinkel, R. T. van Domburg, J. J. Bax, R. Valkema, A. Huurman, H. H. Feringa, and D. Poldermans Risk Stratification of Patients with Angina Pectoris by Stress 99mTc-Tetrofosmin Myocardial Perfusion Imaging J. Nucl. Med., December 1, 2005; 46(12): 2003 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J.W. Chow, J. W. Wong, K. Yoshinaga, T. D. Ruddy, K. Williams, R. A. deKemp, J. DaSilva, and R. S. Beanlands Prognostic Significance of Dipyridamole-Induced ST Depression in Patients with Normal 82Rb PET Myocardial Perfusion Imaging J. Nucl. Med., July 1, 2005; 46(7): 1095 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Mieres, L. J. Shaw, A. Arai, M. J. Budoff, S. D. Flamm, W. G. Hundley, T. H. Marwick, L. Mosca, A. R. Patel, M. A. Quinones, et al. Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation, February 8, 2005; 111(5): 682 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liao, W. T. Smith IV, R. H. Tuttle, L. K. Shaw, R. E. Coleman, and S. Borges-Neto Prediction of Death and Nonfatal Myocardial Infarction in High-Risk Patients: A Comparison Between the Duke Treadmill Score, Peak Exercise Radionuclide Angiography, and SPECT Perfusion Imaging J. Nucl. Med., January 1, 2005; 46(1): 5 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
T M Bateman and E Prvulovich Assessment of prognosis in chronic coronary artery disease Heart, August 1, 2004; 90(suppl_5): v10 - v15. [Full Text] [PDF] |
||||
![]() |
G. A. Beller and D. D. Watson Risk stratification using stress myocardial perfusion imaging: don't neglect the value of clinical variables J. Am. Coll. Cardiol., January 21, 2004; 43(2): 209 - 212. [Full Text] [PDF] |
||||
![]() |
N K Sabharwal and A Lahiri Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease Heart, November 1, 2003; 89(11): 1291 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee Members, F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1318 - 1333. [Full Text] [PDF] |
||||
![]() |
F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, M. D. Cerqueira, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) Circulation, September 16, 2003; 108(11): 1404 - 1418. [Full Text] [PDF] |
||||
![]() |
R. Hachamovitch, S. Hayes, J. D. Friedman, I. Cohen, L. J. Shaw, G. Germano, and D. S. Berman Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1329 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee Members, R. J. Gibbons, G. J. Balady, J. Timothy Bricker, B. R. Chaitman, G. F. Fletcher, V. F. Froelicher, D. B. Mark, B. D. McCallister, A. N. Mooss, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: A report of the American college of cardiology/American heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines) J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1531 - 1540. [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, G. J. Balady, J. Timothy Bricker, B. R. Chaitman, G. F. Fletcher, V. F. Froelicher, D. B. Mark, B. D. McCallister, A. N. Mooss, M. G. O'Reilly, et al. ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines) Circulation, October 1, 2002; 106(14): 1883 - 1892. [Full Text] [PDF] |
||||
![]() |
D.R. Holdright The role of pharmacological stress echo for evaluating chest pain in women Eur. Heart J., January 2, 2001; 22(2): 107 - 109. [PDF] |
||||
![]() |
R. J Gibbons IMAGING TECHNIQUES: Myocardial perfusion imaging Heart, March 1, 2000; 83(3): 355 - 360. [Full Text] |
||||
![]() |
Radionuclide Imaging After Intermediate-Risk Exercise ECG Journal Watch (General), December 10, 1999; 1999(1210): 4 - 4. [Full Text] |
||||
![]() |
R. Hachamovitch, D. S. Berman, H. Kiat, I. Cohen, J. D. Friedman, and L. J. Shaw Value of Stress Myocardial Perfusion Single Photon Emission Computed Tomography in Patients With Normal Resting Electrocardiograms: An Evaluation of Incremental Prognostic Value and Cost-Effectiveness Circulation, February 19, 2002; 105(7): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |